Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorolanib plus Toripalimab in advanced NSCLC
NCT03848611Phase 2Unknown
- Sponsor
- AnewPharma Company, Ltd.
- Start
- Apr 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorolanib in non-small cell lung cancer (NSCLC), sponsored by AnewPharma Company, Ltd.. Status: unknown.
02
Drugs
vorolanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03848611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03848611.